NYSEARCA:HRTS Tema Obesity & Cardiometabolic ETF (HRTS) Price, Holdings, & News $30.58 +0.29 (+0.96%) As of 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsRatings About Tema Obesity & Cardiometabolic ETF (NYSEARCA:HRTS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HRTS alerts:Sign Up Key Stats Today's Range$30.40▼$30.6950-Day Range$28.67▼$32.7052-Week Range$28.56▼$36.03Volume5,610 shsAverage Volume12,353 shsMarket Capitalization$57.80 millionAssets Under Management$524,000.00Dividend YieldN/ANet Expense Ratio0.00%Aggregate RatingModerate Buy ETF OverviewThe Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.Read More… Tema Obesity & Cardiometabolic ETF ExpensesTypeHRTSNYSEARCA ETFsAll ETFsManagement Fee0.00%0.51%0.52%Other Expenses0.00%0.57%0.54%Total Expense0.00%0.73%0.71%Fee Waiver0.00%-0.66%-0.56%Net Expense0.00%0.58%0.60% Receive HRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address HRTS ETF News HeadlinesEli Lilly’s quest for obesity drugs leads to $1B bet on dark genomeSeptember 6, 2024 | seekingalpha.comHRTS: Generating Alpha In Obesity TreatmentJuly 25, 2024 | seekingalpha.comUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 40-year career. During the presentation, Larry reveals a strategy every trader and investor needs to understand. He calls it “Bitcoin Skimming.”January 30, 2025 | Brownstone Research (Ad)HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of UpsideJuly 19, 2024 | seekingalpha.comWeight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up SupplyMay 29, 2024 | msn.comBlack menopausal women almost 5 times less likely to be on HRT than white womenApril 27, 2024 | yahoo.comSee More Headlines HRTS ETF - Frequently Asked Questions How have HRTS shares performed this year? Tema Obesity & Cardiometabolic ETF's stock was trading at $28.87 at the beginning of 2025. Since then, HRTS shares have increased by 5.9% and is now trading at $30.58. View the best growth stocks for 2025 here. How do I buy shares of Tema Obesity & Cardiometabolic ETF? Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tema Obesity & Cardiometabolic ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Obesity & Cardiometabolic ETF investors own include Intuitive Surgical (ISRG), Adobe (ADBE), Accenture (ACN), Alpha Metallurgical Resources (AMR), Arista Networks (ANET), AppLovin (APP) and Arch Resources (ARCH). Fund Details Issuer Fund NameTema Cardiovascular and Metabolics ETF Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:HRTS Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings40 Fund Statistics Assets Under Management$524,000.00 Average Daily Volume$0.00 Discount/Premium0.43% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares1,890,000Beta0.93 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Top 10 HRTS HoldingsEli Lilly and Company (NYSE:LLY)Holding Weight: 8.38%UnitedHealth Group (NYSE:UNH)Holding Weight: 6.04%BridgeBio Pharma (NASDAQ:BBIO)Holding Weight: 4.93%Novo Nordisk A/SHolding Weight: 3.81%AstraZeneca PLCHolding Weight: 3.79%Roche (OTCMKTS:RHHBY)Holding Weight: 3.49%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 3.42%Merck & Co., Inc. (NYSE:MRK)Holding Weight: 3.34%Abbott Laboratories (NYSE:ABT)Holding Weight: 3.23%Thermo Fisher Scientific (NYSE:TMO)Holding Weight: 3.14%Full Holdings DetailsHRTS Sector ExposureHRTS Industry Exposure This page (NYSEARCA:HRTS) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
